ArticleScientific reports2025
Evaluation of biomarkers and immune microenvironment of gestational diabetes mellitus evidence from omics data and machine learning.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Construction of a prediction model for retinopathy of prematurity based on placenta-derived genes and clinical variables.Translational pediatrics · 2026Article
- Recent Advances in the Diagnosis and Management of Gestational Diabetes Mellitus: A Narrative Review.International journal of general medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
This study aimed to identify core genes of Gestational diabetes mellitus (GDM) and explore its immune microenvironment. Using the limma package, we were able to identify differentially expressed genes (DEGs) between GDM and normal placental tissue. Weighted gene co-expression network analysis (WGCNA) and various machine-learning algorithms were subsequently employed to identify core genes that may influence the occurrence of GDM. Analysis was used to evaluate the diagnostic usefulness of the core genes by using the receiver operating characteristic (ROC) analysis method. In gene enrichment analysis, we utilized the CIBERSORT algorithm to assess the immune cell composition in various samples, followed by the application of the Wilcoxon test to evaluate the immune cell content in diabetes samples during pregnancy. Conversely, analysis was done on the relationship between immune cells and core genes. Finally, we used RUN PCA to integrate different data sets and cluster cells with different functions. 527 up-regulated genes were found, and 690 down-regulated were found. Combining the results of the algorithms and ROC analysis, we identified CCL3/FAM3B/IL1RL1 as potential diagnostic biomarkers for GDM, and validated their diagnosibility using an external dataset. The results of the functional enrichment analysis indicated that core genes are associated with immune cells. When compared to pregnant women who were having diabetes, there was a considerable rise in the percentage of macrophages in immunological cells. The expression of three core genes in different cells of different samples showed that the expression of CCL3 was increased in macrophages of GDM. Cell communication analysis showed that macrophage communication was significantly active in GDM, and CCL signal was significantly increased, which mainly played a significant role through CCL3-CCR1 pathway. The findings suggest that CCL3 closely related to GDM occurrence and progression, represent new GDM marker, and that the modification of immune microenvironment plays a significant role in the occurrence of GDM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.